(NewsDirect)
Emergent HealthCorp. (OTC: EMGE) , a curator, developer, and marketer ofproducts in the Regenerative Health Space announced today that it willbe collaborating with Apollo Biowellness, Inc., the entity thatBoustead has engaged to conduct an IPO of the roll up of theregenerative medicine space, previously announced by Emergent on May18, 2023. Apollo is an aggregate of manufacturing, distribution andmarketing of regenerative products and brands in the regenerativespace.
Thispartnership, along with the previously announced spin-off of PharmaZuwill continue to build significant value to Emergent.
As part of the roll-upbeing conducted by Boustead and Apollo Biowellness, effective June 1,2023, Mr. Morrison will take over as President/CEO of ApolloBiowellness.
Mr.Morrison will remain as a member of the Board of Directors of theEmergent and will assume the Title of Chairman of the Board. He willcontinue to be intimately involved with Emergent and the continueddevelopment, marketing and distribution of its products and brands,The two companies will coordinate marketing strategies, manufacturingand work together to expand the products and brands.
Jim Morrison stated,“Since taking the helm of Emergent, I have enjoyed the process ofcreating the Company’s vibrant products and brands in theregenerative biologic space. The opportunity to coordinate betweenEmergent and Apollo and expand the value of these products and brandsas President of Apollo Biowellness is an exciting opportunity and willbring expanded value to Emergent. I look forward to continuing to beinvolved in the dynamic offerings of Emergent going forward.”
Jim Zimbler, a memberof the Board of Directors, and previously the President of theCompany, has been re-appointed as Interim President of the Company,also effective June 1, 2023. In addition to bringing on new seniormanagement, the Company will be announcing a new CFO and a willconduct a new executive search for a new permanent full time CEO towork with the current management and Board and team and Mr. Morrisonand the Apollo Biowellness team. The Company will announce moreManagement updates shortly.
Jim Zimbler stated, “Jim Morrison has done amagnificent job during his tenure as President, and I know he will bea tremendous asset to Apollo Biowellness. I look forward to a closecontinued relationship with Mr. Morrison and leaning on him for hissizable experience and tutelage related to products and brands. Thatwill greatly enhance the value Emergent will receive from the sale ofEvolutionary Biologics and the other entities.”
ABOUT EMERGENT HEALTHCORPORATION
Emergent curates, develops and sells products in theRegenerative Health Space. Its products comprise of ingestibles aswell as topicals for the whole family. The company distributes itsproducts online and through Content Based Shopping using Influencersto position products in their produced content throughout the UnitedStates and Internationally. Its subsidiaries; PharmaZu , is a pure play,e-commerce products and service provider focused on the Pet Community,Pet Pharmacy and Pet Wellness using Influencers and their content,including the pet pharmacy, vet telehealth and pet wellnessbusinesses. EvolutionaryBiologics , is a new kind of biologics company founded for a clearpurpose: bring cutting edge regenerative products to the medicalcommunity. Emergent does not claim any of its products are approved bythe FDA to diagnose, treat, cure or prevent any disease. For moreinformation, please visit Emergent's Website and Social Mediaon .
Before usingany products, you should always consult with your Veterinarian and/orFamily Doctor.
SAFE HARBOR STATEMENT
This press release contains forward-lookingstatements that can be identified by terminology such as“believes,” “expects,” “potential,” “plans,”“suggests,” “may,” “should,” “could,” “intends,”or similar expressions. Many forward-looking statements involve knownand unknown risks, uncertainties and other factors that may causeactual results to be materially different from any future resultsimplied by such statements. These factors include, but are not limitedto, our ability to continue to enhance our products and systems toaddress industry changes, our ability to expand our customer base andretain existing customers, our ability to effectively compete in ourmarket segment, the lack of public information on our company, ourability to raise sufficient capital to fund our business, operations,our ability to continue as a going concern, and a limited publicmarket for our common stock, among other risks. Many factors aredifficult to predict accurately and are generally beyond thecompany's control. Forward-looking statements speak only as to thedate they are made, and we do not undertake to update forward-lookingstatements to reflect circumstances or events that occur after thedate the forward-looking statements are made.
FOR MORE INFORMATION,PLEASE CONTACT:
Jim Morrison, Chairman of the Board
James W. Zimbler – InterimPresident/Interim CEO
Emergent HealthCorporation Website
i nfo@emergenthealthcompany.com
ContactDetails
Emergent Health Corp.
info@emergenthealthcompany.com
CompanyWebsite
https://emergenthealthcompany.com/
Copyright (c) 2023 TheNewswire - All rights reserved.